The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, February 18, 2022
Health Canada authorized Novavax's Nuvaxovid COVID-19 vaccine for the prevention of COVID-19 in adults 18 years of age and older. This is the fifth ...
read more
Friday, February 18, 2022
FDA has approved Pyrukynd (mitapivat) tablets to treat hemolytic anemia (a disorder in which red blood cells are destroyed faster than they can be ...
read more
Tuesday, February 22, 2022
BioNTech SE and Medigene AG, a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have ...
read more
Friday, February 25, 2022
The FDA approved the first generic of Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility “off” episodes (“end-of-dose ...
read more
Friday, February 25, 2022
Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
read more
Friday, February 25, 2022
Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to its novel investigational ...
read more
Friday, February 25, 2022
Jardiance was originally approved by the FDA in 2014 as a supplement to diet and exercise to improve glucose control in adults with type 2 diabetes. ...
read more
Friday, February 25, 2022
The FDA has revised the emergency use authorization for Evusheld (tixagevimab co-packaged with cilgavimab) to change the initial dose for the ...
read more
Monday, February 28, 2022
Astellas Pharma Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has confirmed its...
read more
Monday, February 28, 2022
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for...
read more
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier,...
read more
Alexion, AstraZeneca’s Rare Disease group, has closed an exclusive global collaboration and license agreement with Neurimmune AG for NI006, an ...
read more
Wednesday, March 02, 2022
SAB Biotherapeutics reported that due to low hospitalization and death rates in the trial, the National Institutes of Health’s (NIH) ACTIV-2 Program ...
read more
Wednesday, March 02, 2022
Amneal Pharmaceuticals, Inc. announced the FDA has approved the Biologics License Application (BLA) for filgrastim-ayow, a biosimilar referencing ...
read more
Wednesday, March 02, 2022
FDA has granted accelerated approval for Vonjo (pacritinib) capsules to treat adults who have a rare form of a bone marrow disorder known as ...
read more